Arthritis Prevalence: Which Case Definition Should Be Used for Surveillance? Comment on the Article by Jafarzadeh and Felson
Arthritis Rheumatol
.
2019 Jan;71(1):172-175.
doi: 10.1002/art.40733.
Epub 2018 Dec 4.
Authors
Louise B Murphy
1
,
Jeffrey J Sacks
2
,
Charles G Helmick
1
,
Teresa J Brady
1
,
Kamil E Barbour
1
,
Jennifer M Hootman
1
,
Michael A Boring
3
,
Susan Moss
4
,
Dana Guglielmo
1
5
,
Kristina A Theis
1
Affiliations
1
Centers for Disease Control and Prevention, Atlanta, GA.
2
Sue Binder Consulting, Inc., Decatur, GA.
3
Cutting Edge Technologies and Solutions, Mesa, AZ.
4
G2S Corporation, San Antonio, TX.
5
Oak Ridge Institute for Science and Education, Oak Ridge, TN.
PMID:
30251477
PMCID:
PMC10506797
DOI:
10.1002/art.40733
No abstract available
Publication types
Letter
Comment
MeSH terms
Antirheumatic Agents*
Arthritis*
Humans
Prevalence
United States
Substances
Antirheumatic Agents
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States